Antibody patenting: a practitioner's guide to drafting, prosecution and enforcement
Antibody Patenting' provides a comprehensive and in-depth analysis of all aspects relating to the patenting of antibodies from initial drafting and prosecution to enforcement. Antibodies have revolutionized medicine and biotechnology, and have become indispensable tools in therapy, diagnostics,...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Alphen aan den Rijn
Wolters Kluwer
[2019]
|
| Schriftenreihe: | AIPPI law series
Volume 5 |
| Zusammenfassung: | Antibody Patenting' provides a comprehensive and in-depth analysis of all aspects relating to the patenting of antibodies from initial drafting and prosecution to enforcement. Antibodies have revolutionized medicine and biotechnology, and have become indispensable tools in therapy, diagnostics, analytics, and research. Therapeutic antibodies, for example, have come to dominate the ranks of blockbuster drugs, currently accounting for 10 out of the top 15 best-selling medicines. At the same time, a body of case law dealing specifically with the patentability of antibody-related inventions and the enforcement of antibody patents has emerged in major jurisdictions. The, at times, significant divergences between different jurisdictions have been compounded by recent decisions in the United States, most notably Amgen v. Sanofi, 872 F.3d 1367 (Fed. Cir. 2017), which have severely curtailed the possibilities to obtain broad antibody patents. It is therefore essential to understand how antibody inventions are assessed in different jurisdictions in order to secure an optimal patent protection and to successfully enforce such patents.00This book covers 23 of the most important IP jurisdictions worldwide ? i.e., the European Patent Office, France, Germany, Italy, the Netherlands, Poland, Spain, Switzerland, the United Kingdom, Israel, the United States of America, Argentina, the Andean Community (Bolivia, Colombia, Ecuador, and Peru), Brazil, Canada, Chile, Mexico, China, India, Japan, Singapore, South Korea, and Australia |
| Beschreibung: | xlviii, 426 Seiten |
| ISBN: | 9789403510736 9403510730 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV046195755 | ||
| 003 | DE-604 | ||
| 005 | 20200319 | ||
| 007 | t | ||
| 008 | 191011s2019 |||| 00||| eng d | ||
| 020 | |a 9789403510736 |9 978-94-035-1073-6 | ||
| 020 | |a 9403510730 |9 94-035-1073-0 | ||
| 035 | |a (OCoLC)1249682357 | ||
| 035 | |a (DE-599)BVBBV046195755 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M382 |a DE-19 | ||
| 245 | 1 | 0 | |a Antibody patenting |b a practitioner's guide to drafting, prosecution and enforcement |c Edited by Jürgen Meier; Oswin Ridderbusch |
| 264 | 1 | |a Alphen aan den Rijn |b Wolters Kluwer |c [2019] | |
| 300 | |a xlviii, 426 Seiten | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a AIPPI law series |v Volume 5 | |
| 520 | 3 | |a Antibody Patenting' provides a comprehensive and in-depth analysis of all aspects relating to the patenting of antibodies from initial drafting and prosecution to enforcement. Antibodies have revolutionized medicine and biotechnology, and have become indispensable tools in therapy, diagnostics, analytics, and research. Therapeutic antibodies, for example, have come to dominate the ranks of blockbuster drugs, currently accounting for 10 out of the top 15 best-selling medicines. At the same time, a body of case law dealing specifically with the patentability of antibody-related inventions and the enforcement of antibody patents has emerged in major jurisdictions. The, at times, significant divergences between different jurisdictions have been compounded by recent decisions in the United States, most notably Amgen v. Sanofi, 872 F.3d 1367 (Fed. Cir. 2017), which have severely curtailed the possibilities to obtain broad antibody patents. It is therefore essential to understand how antibody inventions are assessed in different jurisdictions in order to secure an optimal patent protection and to successfully enforce such patents.00This book covers 23 of the most important IP jurisdictions worldwide ? i.e., the European Patent Office, France, Germany, Italy, the Netherlands, Poland, Spain, Switzerland, the United Kingdom, Israel, the United States of America, Argentina, the Andean Community (Bolivia, Colombia, Ecuador, and Peru), Brazil, Canada, Chile, Mexico, China, India, Japan, Singapore, South Korea, and Australia | |
| 700 | 1 | |a Meier, Jürgen |d 1957- |0 (DE-588)101546534X |4 edt | |
| 700 | 1 | |a Ridderbusch, Oswin |0 (DE-588)1175264520 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe, PDF |z 978-94-035-1081-1 |
| 830 | 0 | |a AIPPI law series |v Volume 5 |w (DE-604)BV043191842 |9 5 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031575019 | ||
Datensatz im Suchindex
| _version_ | 1804180573820813312 |
|---|---|
| any_adam_object | |
| author2 | Meier, Jürgen 1957- Ridderbusch, Oswin |
| author2_role | edt edt |
| author2_variant | j m jm o r or |
| author_GND | (DE-588)101546534X (DE-588)1175264520 |
| author_facet | Meier, Jürgen 1957- Ridderbusch, Oswin |
| building | Verbundindex |
| bvnumber | BV046195755 |
| ctrlnum | (OCoLC)1249682357 (DE-599)BVBBV046195755 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02657nam a2200325 cb4500</leader><controlfield tag="001">BV046195755</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20200319 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">191011s2019 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789403510736</subfield><subfield code="9">978-94-035-1073-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9403510730</subfield><subfield code="9">94-035-1073-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1249682357</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046195755</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antibody patenting</subfield><subfield code="b">a practitioner's guide to drafting, prosecution and enforcement</subfield><subfield code="c">Edited by Jürgen Meier; Oswin Ridderbusch</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Alphen aan den Rijn</subfield><subfield code="b">Wolters Kluwer</subfield><subfield code="c">[2019]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xlviii, 426 Seiten</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">AIPPI law series</subfield><subfield code="v">Volume 5</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Antibody Patenting' provides a comprehensive and in-depth analysis of all aspects relating to the patenting of antibodies from initial drafting and prosecution to enforcement. Antibodies have revolutionized medicine and biotechnology, and have become indispensable tools in therapy, diagnostics, analytics, and research. Therapeutic antibodies, for example, have come to dominate the ranks of blockbuster drugs, currently accounting for 10 out of the top 15 best-selling medicines. At the same time, a body of case law dealing specifically with the patentability of antibody-related inventions and the enforcement of antibody patents has emerged in major jurisdictions. The, at times, significant divergences between different jurisdictions have been compounded by recent decisions in the United States, most notably Amgen v. Sanofi, 872 F.3d 1367 (Fed. Cir. 2017), which have severely curtailed the possibilities to obtain broad antibody patents. It is therefore essential to understand how antibody inventions are assessed in different jurisdictions in order to secure an optimal patent protection and to successfully enforce such patents.00This book covers 23 of the most important IP jurisdictions worldwide ? i.e., the European Patent Office, France, Germany, Italy, the Netherlands, Poland, Spain, Switzerland, the United Kingdom, Israel, the United States of America, Argentina, the Andean Community (Bolivia, Colombia, Ecuador, and Peru), Brazil, Canada, Chile, Mexico, China, India, Japan, Singapore, South Korea, and Australia</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meier, Jürgen</subfield><subfield code="d">1957-</subfield><subfield code="0">(DE-588)101546534X</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ridderbusch, Oswin</subfield><subfield code="0">(DE-588)1175264520</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe, PDF</subfield><subfield code="z">978-94-035-1081-1</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">AIPPI law series</subfield><subfield code="v">Volume 5</subfield><subfield code="w">(DE-604)BV043191842</subfield><subfield code="9">5</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031575019</subfield></datafield></record></collection> |
| id | DE-604.BV046195755 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:37:55Z |
| institution | BVB |
| isbn | 9789403510736 9403510730 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031575019 |
| oclc_num | 1249682357 |
| open_access_boolean | |
| owner | DE-M382 DE-19 DE-BY-UBM |
| owner_facet | DE-M382 DE-19 DE-BY-UBM |
| physical | xlviii, 426 Seiten |
| publishDate | 2019 |
| publishDateSearch | 2019 |
| publishDateSort | 2019 |
| publisher | Wolters Kluwer |
| record_format | marc |
| series | AIPPI law series |
| series2 | AIPPI law series |
| spelling | Antibody patenting a practitioner's guide to drafting, prosecution and enforcement Edited by Jürgen Meier; Oswin Ridderbusch Alphen aan den Rijn Wolters Kluwer [2019] xlviii, 426 Seiten txt rdacontent n rdamedia nc rdacarrier AIPPI law series Volume 5 Antibody Patenting' provides a comprehensive and in-depth analysis of all aspects relating to the patenting of antibodies from initial drafting and prosecution to enforcement. Antibodies have revolutionized medicine and biotechnology, and have become indispensable tools in therapy, diagnostics, analytics, and research. Therapeutic antibodies, for example, have come to dominate the ranks of blockbuster drugs, currently accounting for 10 out of the top 15 best-selling medicines. At the same time, a body of case law dealing specifically with the patentability of antibody-related inventions and the enforcement of antibody patents has emerged in major jurisdictions. The, at times, significant divergences between different jurisdictions have been compounded by recent decisions in the United States, most notably Amgen v. Sanofi, 872 F.3d 1367 (Fed. Cir. 2017), which have severely curtailed the possibilities to obtain broad antibody patents. It is therefore essential to understand how antibody inventions are assessed in different jurisdictions in order to secure an optimal patent protection and to successfully enforce such patents.00This book covers 23 of the most important IP jurisdictions worldwide ? i.e., the European Patent Office, France, Germany, Italy, the Netherlands, Poland, Spain, Switzerland, the United Kingdom, Israel, the United States of America, Argentina, the Andean Community (Bolivia, Colombia, Ecuador, and Peru), Brazil, Canada, Chile, Mexico, China, India, Japan, Singapore, South Korea, and Australia Meier, Jürgen 1957- (DE-588)101546534X edt Ridderbusch, Oswin (DE-588)1175264520 edt Erscheint auch als Online-Ausgabe, PDF 978-94-035-1081-1 AIPPI law series Volume 5 (DE-604)BV043191842 5 |
| spellingShingle | Antibody patenting a practitioner's guide to drafting, prosecution and enforcement AIPPI law series |
| title | Antibody patenting a practitioner's guide to drafting, prosecution and enforcement |
| title_auth | Antibody patenting a practitioner's guide to drafting, prosecution and enforcement |
| title_exact_search | Antibody patenting a practitioner's guide to drafting, prosecution and enforcement |
| title_full | Antibody patenting a practitioner's guide to drafting, prosecution and enforcement Edited by Jürgen Meier; Oswin Ridderbusch |
| title_fullStr | Antibody patenting a practitioner's guide to drafting, prosecution and enforcement Edited by Jürgen Meier; Oswin Ridderbusch |
| title_full_unstemmed | Antibody patenting a practitioner's guide to drafting, prosecution and enforcement Edited by Jürgen Meier; Oswin Ridderbusch |
| title_short | Antibody patenting |
| title_sort | antibody patenting a practitioner s guide to drafting prosecution and enforcement |
| title_sub | a practitioner's guide to drafting, prosecution and enforcement |
| volume_link | (DE-604)BV043191842 |
| work_keys_str_mv | AT meierjurgen antibodypatentingapractitionersguidetodraftingprosecutionandenforcement AT ridderbuschoswin antibodypatentingapractitionersguidetodraftingprosecutionandenforcement |